Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual

Fertility and Sterility

Volumn 94, Issue 3, 2010, Pages 1097.e13-1097.e15

  García Malpartida, Katherine ^a   Martín Gorgojo, Alejandro ^a   Rocha, Milagros ^a   Gómez Balaguer, Marcelino ^a   Hernández Mijares, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Cross sex hormone therapy; cyproterone acetate; estrogens; hyperprolactinemia; male to female transsexual; prolactinoma

Indexed keywords

CABERGOLINE; CORTICOTROPIN; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASTHENIA; BLOOD ANALYSIS; BREAST RECONSTRUCTION; CASE REPORT; CHEMOLUMINESCENCE; DRUG INDUCED CANCER; DRUG WITHDRAWAL; FREE THYROXINE INDEX; GALACTORRHEA; GENDER IDENTITY DISORDER; GROWTH HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; KARYOTYPE 46,XY; LOW DRUG DOSE; MALE; MALE TO FEMALE TRANSSEXUAL; MASTALGIA; MICROADENOMA; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SELLA TURCICA; THYROTROPIN BLOOD LEVEL;

EID: 77955579330     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.01.076     Document Type: Article

References (10)

1. L.J. Gooren, E.J. Giltay, and M.C. Bunck Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience J Clin Endocrinol Metab 93 2008 19 25
2. L.J. Gooren, J. Assies, H. Asscheman, R. de Slegte, and H. van Kessel Estrogen-induced prolactinoma in a man J Clin Endocrinol Metab 66 1988 444 446
3. K. Kovacs, L. Stefaneanu, S. Ezzat, and H.S. Smyth Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration: a morphologic study Arch Pathol Lab Med 118 1994 562 565
4. O. Serri, D. Noiseux, F. Robert, and J. Hardy Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient J Clin Endocrinol Metab 81 1996 3177 3179
5. H. Asscheman, L.J. Gooren, J. Assies, J.P. Smits, and R. de Slegte Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals Clin Endocrinol (Oxf) 28 1988 583 588
6. Bunck MC, Debono M, Giltay EJ, Verheijen AT, Diamant M, Gooren LJ. Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages. BMJ Case Reports. Published online August 10, 2009.
7. P.H. Willemse, L.D. Dikkeschei, N.H. Mulder, E. van der Ploeg, D.T. Sleijfer, and E.G. de Vries Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer Eur J Cancer Clin Oncol 24 1998 417 421
8. A.P. Heaney, M. Fernando, and S. Melmed Functional role of estrogen in pituitary tumour pathogenesis J Clin Invest 109 2002 277 283
9. G. Piroli, A.E. Lima, G. Díaz-Torga, and A.F. De Nicola Biochemical parameters in the anterior pituitary during the course of tumorigenesis induced by diethylstilbestrol treatment J Steroid Biochem Mol Biol 51 1994 183 189
10. R.K. Xu, X.M. Wu, A.K. Di, J.N. Xu, C.S. Pang, and S.F. Pang Pituitary prolactin-secreting tumor formation: recent developments Biol Signals Recept 9 2000 1 20